News
Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal biological ...
Radiation therapy is an established method of cancer treatment. It works by subjecting tumor cells to ionizing radiation, damaging their genetic material and, ideally, eliminating the tumor.
Radiation therapy is an established method of cancer treatment. It works by subjecting tumor cells to ionizing radiation, ...
For many cancer patients, side effects from radiation can be debilitating. But a new way of delivering radiation treatment has proven effective at eliminating a hard-to-treat cancer with the only side ...
Researchers in Canada are developing a low-cost orthovoltage radiotherapy system for use in low-resource and geographically ...
Prostate cancer is the most common cancer in men worldwide. Thanks to scientific breakthroughs, there are more ways than ever to treat it — especially when it’s caught early. One ...
The global intraoperative radiation therapy systems market is poised for significant growth, with projections indicating a substantial increase in value over the next decade. According to recent ...
Telix Pharmaceuticals Ltd.’s glioblastoma theranostic, TLX-101, is showing promising overall survival in a phase II trial in ...
Telix reports early Phase 2 data showing TLX101 improves survival in recurrent brain cancer patients, with no serious side effects observed.
The US Radiotherapy Market is projected to reach US$2.49 billion by 2030 from US$3.25 billion in 2024, at a CAGR of 4.6%. The US radiotherapy ...
When it came to the study’s secondary endpoints of survival, Telix pointed to a median overall survival (OS) rate of 12.4 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results